Leukemia With TCF3-ZNF384 Rearrangement as a Distinct Subtype of Disease With Distinct Treatments: Perspectives From A Case Report and Literature Review

Clinical characteristics and outcomes of B-ALL with ZNF384 rearrangements: a retrospective analysis by the Ponte di Legno Childhood ALL Working Group

(2021) Shinsuke Hirabayashi et al.   LEUKEMIA

Determining the Appropriate Treatment for T-Cell Acute Lymphoblastic Leukemia With SET-CAN/NUP214 Fusion: Perspectives From a Case Report and Literature Review

(2021) Na Lin et al.   Frontiers in Oncology

Selectively targeting FLT3-ITD mutants over FLT3-wt by a novel inhibitor for acute myeloid leukemia

(2020) Aoli Wang et al.   HAEMATOLOGICA

Response to letter by Abdo, et al.

(2020) Clara Bueno et al.   BLOOD

Emergence of a prominent myeloid clone in a ZNF384 ‐rearranged B‐cell precursor acute lymphoblastic leukaemia post‐corticosteroid pre‐phase therapy

(2020) Alpeshkumar Bipinbhai Kapadia et al.   PEDIATRIC BLOOD & CANCER

Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort

(2019) Marketa Zaliova et al.   HAEMATOLOGICA

Discovery and characterization of a novel highly potent and selective type II native and drug-resistant V299L mutant BCR-ABL inhibitor (CHMFL-ABL-039) for Chronic Myeloid Leukemia (CML)

(2019) Jiaxin Wu et al.   CANCER BIOLOGY & THERAPY

Natural history and cell-of-origin of TCF3-ZNF384 and PTPN11 mutations in monozygotic twins with concordant BCP-ALL

(2019) Clara Bueno et al.   BLOOD

Very late relapse cases of TCF3‐ZNF384 ‐positive acute lymphoblastic leukemia

(2019) Akira Nishimura et al.   PEDIATRIC BLOOD & CANCER

Characterization of TCF3 rearrangements in pediatric B-lymphoblastic leukemia/lymphoma by mate-pair sequencing (MPseq) identifies complex genomic rearrangements and a novel TCF3/TEF gene fusion

(2019) Ross A. Rowsey et al.   Blood Cancer Journal

How advanced are we in targeting novel subtypes of ALL?

(2019) Charles G. Mullighan   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Myeloid lineage switch following chimeric antigen receptor T-cell therapy in a patient with TCF3-ZNF384 fusion-positive B-lymphoblastic leukemia

(2018) Matthew J. Oberley et al.   PEDIATRIC BLOOD & CANCER

The genetic basis and cell of origin of mixed phenotype acute leukaemia

(2018) Thomas B. Alexander et al.   NATURE

Discovery of N-(4-(6-Acetamidopyrimidin-4-yloxy)phenyl)-2-(2-(trifluoromethyl)phenyl)acetamide (CHMFL-FLT3-335) as a Potent FMS-like Tyrosine Kinase 3 Internal Tandem Duplication (FLT3-ITD) Mutant Selective Inhibitor for Acute Myeloid Leukemia

(2018) Xiaofei Liang et al.   JOURNAL OF MEDICINAL CHEMISTRY

Transcriptome sequencing in pediatric acute lymphoblastic leukemia identifies fusion genes associated with distinct DNA methylation profiles

(2017) Yanara Marincevic-Zuniga et al.   Journal of Hematology & Oncology

High-dose methotrexate therapy significantly improved survival of adult acute lymphoblastic leukemia: a phase III study by JALSG

(2017) T Sakura et al.   LEUKEMIA

Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemia

(2016) Malachi Griffith et al.   EXPERIMENTAL HEMATOLOGY

Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities ofEP300andCREBBP

(2016) Maoxiang Qian et al.   GENOME RESEARCH

ZNF384 -related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype

(2016) Shinsuke Hirabayashi et al.   HAEMATOLOGICA

LNK/SH2B3 regulates IL-7 receptor signaling in normal and malignant B-progenitors

(2016) Ying Cheng et al.   JOURNAL OF CLINICAL INVESTIGATION

Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults

(2016) Takahiko Yasuda et al.   NATURE GENETICS

Frequency and outcome of pediatric acute lymphoblastic leukemia withZNF384gene rearrangements including a novel translocation resulting in anARID1B/ZNF384gene fusion

(2016) Mary Shago et al.   PEDIATRIC BLOOD & CANCER

ZNF384 -related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype

(2016) Shinsuke Hirabayashi et al.   HAEMATOLOGICA

Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia

(2016) Yuan-Fang Liu et al.   EBioMedicine

E2A-ZNF384 and NOL1-E2A fusion created by a cryptic t(12;19)(p13.3; p13.3) in acute leukemia

(2008) C-h Zhong et al.   LEUKEMIA

The prognostic significance of leukemic cells clearance kinetics evaluation during the initial course of induction therapy with HAD (homoharringtonine, cytosine arabinoside, daunorubicin) in patients with de novo acute myeloid leukemia

(2007) Zhijian Xiao et al.   AMERICAN JOURNAL OF HEMATOLOGY